VYNE Financial Statements

Balance sheet, income statement, cash flow, and dividends for Vyne Therapeutics Inc (VYNE).


$49.42M Market Cap.

As of 03/06/2025 5:00 PM ET (MRY) • Disclaimer

VYNE Market Cap. (MRY)


VYNE Shares Outstanding (MRY)


VYNE Assets (MRY)


Total Assets

$66.91M

Total Liabilities

$14.82M

Total Investments

$41.59M

VYNE Income (MRY)


Revenue

$501.00K

Net Income

-$39.83M

Operating Expense

$44.14M

VYNE Cash Flow (MRY)


CF Operations

-$33.97M

CF Investing

$23.36M

CF Financing

-$141.00K

VYNE Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

VYNE Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$66,905,000 (-31.51%)

$97,685,000 (139.67%)

$40,758,000 (-39.21%)

$67,046,000 (-28.48%)

Assets Current

$64,437,000 (-32.85%)

$95,963,000 (150.72%)

$38,275,000 (-39.42%)

$63,186,000 (-27.59%)

Assets Non-Current

$2,468,000 (43.32%)

$1,722,000 (-30.65%)

$2,483,000 (-35.67%)

$3,860,000 (-40.46%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$52,086,000 (-41.30%)

$88,735,000 (184.39%)

$31,202,000 (-35.85%)

$48,636,000 (29.72%)

Property Plant & Equipment Net

$206,000 (-0.48%)

$207,000 (0%)

$0 (0%)

$692,000 (-67.63%)

Cash & Equivalents

$19,926,000 (-35.04%)

$30,674,000 (-0.97%)

$30,975,000 (-27.72%)

$42,855,000 (-26.64%)

Accumulated Other Comprehensive Income

$20,000 (-23.08%)

$26,000 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$41,590,000 (-33.60%)

$62,633,000 (0%)

$0 (0%)

$0 (0%)

Investments Current

$41,590,000 (-33.60%)

$62,633,000 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$173,000 (-97.72%)

$7,583,000 (-52.06%)

Trade & Non-Trade Payables

$2,707,000 (63.17%)

$1,659,000 (-30.47%)

$2,386,000 (-63.35%)

$6,510,000 (36.19%)

Accumulated Retained Earnings (Deficit)

-$731,170,000 (-5.76%)

-$691,336,000 (-4.32%)

-$662,735,000 (-3.63%)

-$639,525,000 (-12.95%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$99,000 (-53.74%)

$214,000 (0%)

$0 (0%)

$349,000 (-99.00%)

Debt Current

$99,000 (-13.91%)

$115,000 (0%)

$0 (0%)

$349,000 (-53.90%)

Debt Non-Current

$0 (0%)

$99,000 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$14,819,000 (65.58%)

$8,950,000 (-4.23%)

$9,345,000 (-49.24%)

$18,410,000 (-67.27%)

Liabilities Current

$14,819,000 (96.59%)

$7,538,000 (-19.34%)

$9,345,000 (-49.24%)

$18,410,000 (-15.41%)

Liabilities Non-Current

$0 (0%)

$1,412,000 (0%)

$0 (0%)

$0 (0%)

VYNE Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$501,000 (18.16%)

$424,000 (-11.11%)

$477,000 (-48.76%)

$931,000 (-95.57%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$13,192,000 (-1.37%)

$13,375,000 (-18.38%)

$16,387,000 (-19.27%)

$20,299,000 (-77.33%)

Research & Development Expense

$30,946,000 (89.77%)

$16,307,000 (-11.30%)

$18,385,000 (-5.93%)

$19,543,000 (-55.11%)

Operating Expenses

$44,138,000 (48.70%)

$29,682,000 (-14.64%)

$34,772,000 (-12.73%)

$39,842,000 (-85.36%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$5,610,000 (27.79%)

Income Tax Expense

$4,000 (0%)

$0 (0%)

$13,000 (102.90%)

-$448,000 (-73.64%)

Net Loss Income from Discontinued Operations

$27,000 (-95.34%)

$580,000 (105.40%)

-$10,735,000 (-136.86%)

$29,121,000 (0%)

Consolidated Income

-$39,834,000 (-40.00%)

-$28,452,000 (-22.59%)

-$23,210,000 (68.35%)

-$73,329,000 (71.31%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$39,834,000 (-40.00%)

-$28,452,000 (-22.59%)

-$23,210,000 (68.35%)

-$73,329,000 (71.31%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$39,834,000 (-40.00%)

-$28,452,000 (-22.59%)

-$23,210,000 (68.35%)

-$73,329,000 (71.31%)

Weighted Average Shares

$42,589,000 (314.57%)

$10,273,000 (222.44%)

$3,186,000 (11.44%)

$2,859,000 (58.75%)

Weighted Average Shares Diluted

$42,589,000 (314.57%)

$10,273,000 (222.44%)

$3,186,000 (11.44%)

$2,859,000 (58.75%)

Earning Before Interest & Taxes (EBIT)

-$39,830,000 (-39.99%)

-$28,452,000 (-22.65%)

-$23,197,000 (65.97%)

-$68,167,000 (72.89%)

Gross Profit

$501,000 (18.16%)

$424,000 (-11.11%)

$477,000 (-48.76%)

$931,000 (-95.25%)

Operating Income

-$43,637,000 (-49.15%)

-$29,258,000 (14.69%)

-$34,295,000 (11.86%)

-$38,911,000 (84.59%)

VYNE Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$23,365,000 (140.74%)

-$57,354,000 (-466.08%)

$15,667,000 (1425.51%)

$1,027,000 (-98.85%)

Net Cash Flow from Financing

-$141,000 (-100.17%)

$82,394,000 (4884.51%)

$1,653,000 (-95.84%)

$39,777,000 (-35.64%)

Net Cash Flow from Operations

-$33,972,000 (-34.06%)

-$25,341,000 (13.22%)

-$29,200,000 (48.20%)

-$56,367,000 (58.88%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$10,748,000 (-3470.76%)

-$301,000 (97.47%)

-$11,880,000 (23.67%)

-$15,563,000 (-212.51%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$5,000,000 (-68.09%)

$15,667,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$23,482,000 (137.66%)

-$62,354,000 (0%)

$0 (0%)

$1,027,000 (-97.97%)

Capital Expenditure

-$117,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$36,432,000 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$82,821,000 (5643.48%)

$1,442,000 (-98.12%)

$76,503,000 (23.49%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$3,303,000 (-0.06%)

$3,305,000 (-23.09%)

$4,297,000 (-46.82%)

$8,080,000 (-55.36%)

Depreciation Amortization & Accretion

$4,000 (0%)

$0 (0%)

$72,000 (-33.94%)

$109,000 (-68.04%)

VYNE Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (7.07%)

Profit Margin

-7950.90% (-18.49%)

-6710.40% (-37.91%)

-4865.80% (38.22%)

-7876.40% (-546.99%)

EBITDA Margin

-7949.30% (-18.46%)

-6710.40% (-38.42%)

-4848.00% (33.68%)

-7310.20% (-511.17%)

Return on Average Equity (ROAE)

-58.20% (26.42%)

-79.10% (-49.53%)

-52.90% (50.33%)

-106.50% (76.24%)

Return on Average Assets (ROAA)

-49.60% (22.74%)

-64.20% (-43.30%)

-44.80% (34.12%)

-68.00% (67.21%)

Return on Sales (ROS)

-7950.10% (-18.47%)

-6710.40% (-37.99%)

-4863.10% (33.58%)

-7321.90% (-511.33%)

Return on Invested Capital (ROIC)

-83.50% (61.59%)

-217.40% (64.27%)

-608.40% (-43.97%)

-422.60% (9.68%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-3.6 (-329.83%)

-0.84 (-125.88%)

-0.37 (48.18%)

-0.72 (10.72%)

Price to Sales Ratio (P/S)

284.78 (404.45%)

56.45 (213.04%)

18.03 (-68.01%)

56.38 (477.68%)

Price to Book Ratio (P/B)

0.95 (159.29%)

0.37 (31.18%)

0.28 (-75.13%)

1.12 (-84.14%)

Debt to Equity Ratio (D/E)

0.28 (182.18%)

0.1 (-66.33%)

0.3 (-20.84%)

0.38 (-74.73%)

Earnings Per Share (EPS)

-0.93 (66.55%)

-2.78 (61.81%)

-7.28 (71.61%)

-25.64 (81.92%)

Sales Per Share (SPS)

0.01 (-70.73%)

0.04 (-72.67%)

0.15 (-53.99%)

0.33 (-97.20%)

Free Cash Flow Per Share (FCFPS)

-0.8 (67.57%)

-2.47 (73.08%)

-9.16 (53.51%)

-19.72 (74.12%)

Book Value Per Share (BVPS)

1.22 (-85.84%)

8.64 (-11.79%)

9.79 (-42.43%)

17.01 (-18.28%)

Tangible Assets Book Value Per Share (TABVPS)

1.57 (-83.48%)

9.51 (-25.67%)

12.79 (-45.45%)

23.45 (-54.95%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (-200.00%)

1 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.83 (-39.46%)

-0.6 (-151.46%)

1.16 (3005.00%)

-0.04 (95.57%)

Asset Turnover

0.01 (-40.00%)

0.01 (11.11%)

0.01 (0.00%)

0.01 (-94.71%)

Current Ratio

4.35 (-65.85%)

12.73 (210.82%)

4.1 (19.35%)

3.43 (-14.39%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$34,089,000 (-34.52%)

-$25,341,000 (13.22%)

-$29,200,000 (48.20%)

-$56,367,000 (58.91%)

Enterprise Value (EV)

$33,221,301 (95.21%)

$17,018,565 (163.33%)

-$26,871,626 (-1084.57%)

$2,729,270 (-98.80%)

Earnings Before Tax (EBT)

-$39,830,000 (-39.99%)

-$28,452,000 (-22.65%)

-$23,197,000 (68.56%)

-$73,777,000 (71.16%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$39,826,000 (-39.98%)

-$28,452,000 (-23.04%)

-$23,125,000 (66.02%)

-$68,058,000 (72.90%)

Invested Capital

$32,259,000 (-45.95%)

$59,687,000 (13527.17%)

$438,000 (-92.85%)

$6,130,000 (-87.32%)

Working Capital

$49,618,000 (-43.89%)

$88,425,000 (205.65%)

$28,930,000 (-35.39%)

$44,776,000 (-31.63%)

Tangible Asset Value

$66,905,000 (-31.51%)

$97,685,000 (139.67%)

$40,758,000 (-39.21%)

$67,046,000 (-28.48%)

Market Capitalization

$49,417,301 (51.96%)

$32,520,565 (273.57%)

$8,705,374 (-84.05%)

$54,588,270 (-79.42%)

Average Equity

$68,465,500 (90.26%)

$35,985,750 (-17.92%)

$43,839,750 (-36.31%)

$68,829,000 (20.71%)

Average Assets

$80,356,750 (81.42%)

$44,293,500 (-14.48%)

$51,794,250 (-51.99%)

$107,878,750 (-12.44%)

Invested Capital Average

$47,697,750 (264.45%)

$13,087,750 (243.24%)

$3,813,000 (-76.36%)

$16,129,500 (-69.98%)

Shares

14,751,433 (5.69%)

13,957,324 (332.89%)

3,224,213 (8.44%)

2,973,217 (27.52%)